Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | SCN1A | P35498 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.43 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 3/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19474886 | 0.92 | GNAO1 (0.50) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL25373345 | 0.81 | MAPK1 (0.38) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL25376405 | 0.81 | SIGMAR1 (0.44) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL84935 | 0.79 | ALDH1A1 (0.61) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL25372634 | 0.79 | SIGMAR1 (0.45) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL25374705 | 0.79 | MAPK1 (0.36) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL25372404 | 0.77 | MAPK1 (0.35) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| Bromide SCHEMBL27075773 | 0.77 | ALDH1A1 (0.59) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| Hydrochloric Acid SCHEMBL25342847 | 0.77 | MAPK1 (0.62) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 | |
| Ammonia Solution, Strong SCHEMBL27204552 | 0.77 | ALDH1A1 (0.59) | SIGMAR1MAPK1ALDH1A1CYP1A2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702066-A1 | USE OF THERMOLATENT CATALYST TO IMPROVE PROPERTIES OF SINGLE-LAYER POLYURETHANE COATINGS | Covestro Deutschland AG (DE) | 2026-03-04 | — | — | EP | claimed |
| WO-2024223201-A1 | USE OF THERMOLATENT CATALYST TO IMPROVE PROPERTIES OF SINGLE-LAYER POLYURETHANE COATINGS | COVESTRO DEUTSCHLAND AG (DE) | 2024-10-31 | — | — | WO | claimed |
| EP-4455177-A1 | USE OF THERMOLATENT CATALYST TO IMPROVE PROPERTIES OF SINGLE-LAYER POLYURETHANE COATINGS | Covestro Deutschland AG (DE) | 2024-10-30 | — | — | EP | claimed |
| EP-3728472-B1 | MOISTURE-CURABLE COMPOSITIONS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-11-29 | — | — | EP | claimed |
| US-11667746-B2 | Moisture-curing compositions | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-06 | — | — | US | claimed |
| US-11555088-B2 | Dual cure method using Zerewitinoff-active H tin catalysts | COVESTRO DEUTSCHLAND AG (DE) | 2023-01-17 | — | — | US | claimed |
| CN-111479875-B | Moisture-curable composition | 科思创德国股份有限公司 | 2022-11-15 | — | — | CN | claimed |
| EP-3601398-B1 | DUAL CURE METHOD USING THERMALLY LATENT TIN CATALYSTS | COVESTRO DEUTSCHLAND AG (DE) | 2021-04-28 | — | — | EP | claimed |
| US-20210087324-A1 | DUAL CURE METHOD USING THERMALLY LATENT TIN CATALYSTS | COVESTRO DEUTSCHLAND AG (DE) | 2021-03-25 | — | — | US | claimed |
| US-20200392275-A1 | MOISTURE-CURING COMPOSITIONS | COVESTRO DEUTSCHLAND AG (DE) | 2020-12-17 | — | — | US | claimed |
| EP-3728472-A1 | MOISTURE-CURING COMPOSITIONS | Covestro Deutschland AG (DE) | 2020-10-28 | — | — | EP | claimed |
| EP-3601398-A1 | DUAL CURE METHOD USING THERMALLY LATENT TIN CATALYSTS | Covestro Deutschland AG (DE) | 2020-02-05 | — | — | EP | claimed |
| EP-3502185-A1 | MOISTURE-CURABLE COMPOSITIONS | Covestro Deutschland AG (DE) | 2019-06-26 | — | — | EP | claimed |
| WO-2018178025-A1 | DUAL CURE METHOD USING THERMALLY LATENT TIN CATALYSTS | COVESTRO DEUTSCHLAND AG (DE) | 2018-10-04 | — | — | WO | claimed |
| EP-3381959-A1 | DUAL CURE METHOD USING THERMALLY LATENT TIN CATALYSTS | Covestro Deutschland AG (DE) | 2018-10-03 | — | — | EP | claimed |
| US-12617955-B2 | Additive production process with a thermoplastic radically cross-linkable construction material | STRATASYS, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| EP-4702066-A1 | USE OF THERMOLATENT CATALYST TO IMPROVE PROPERTIES OF SINGLE-LAYER POLYURETHANE COATINGS | Covestro Deutschland AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-20170368723-A1 | METHOD FOR PRODUCING AN OPTICAL CAST BODY HAVING A HOLOGRAPHIC OPTICAL ELEMENT, AND OPTICAL CAST BODY | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-28 | — | — | US | disclosed |
| WO-2017182429-A1 | THERMOLATENTLY CATALYSED TWO-COMPONENT SYSTEM | COVESTRO DEUTSCHLAND AG (DE) | 2017-10-26 | — | — | WO | disclosed |
| US-20150240024-A1 | POLYISOCYANATE-POLYADDITION PRODUCTIONS | BAYER MATERIALSCIENCE AG (DE) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617955-B2 | Additive production process with a thermoplastic radically cross-linkable construction material | UBE2G2, MTCL3, RAD51 | SIGMAR1 3943/4885MAPK1 2036/4885ALDH1A1 295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.